2024

1. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

   Journal of Clinical Medicine, Vol. 13, Núm. 20

2. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

   Frontiers in Pharmacology, Vol. 15

3. Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes

   Pharmaceuticals, Vol. 17, Núm. 1

4. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

   Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

5. Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

   Rheumatology International, Vol. 44, Núm. 11, pp. 2327-2336

6. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

   European Journal of Internal Medicine, Vol. 129, pp. 78-86

7. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

   Biomedicines, Vol. 12, Núm. 4

8. Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis

   Rheumatology, Vol. 63, Núm. 11, pp. 3106-3114

9. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

   RMD open, Vol. 10, Núm. 1

10. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199

11. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

12. Mitochondrial Role on Cellular Apoptosis, Autophagy, and Senescence during Osteoarthritis Pathogenesis

    Cells, Vol. 13, Núm. 11

13. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

14. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis

    Pharmaceuticals, Vol. 17, Núm. 9

15. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments

    Seminars in Arthritis and Rheumatism, Vol. 65

16. Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study

    Advances in Therapy, Vol. 41, Núm. 1, pp. 315-330

17. SER recommendations on treatment of refractory Behçet's syndrome

    Reumatologia Clinica, Vol. 20, Núm. 4, pp. 204-217

18. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

19. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Genome Biology, Vol. 25, Núm. 1

20. Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohort

    Osteoarthritis and Cartilage Open, Vol. 6, Núm. 3